Étienne Chatelut
Impact in
Papers in
- Oncology 81
- Cancer Treatment and Pharmacology 30
- Colorectal Cancer Treatments and Studies 19
- Lung Cancer Research Studies 13
-
- Cancer therapeutics and mechanisms 34
- Co-authors
- Pierre Canal (59 shared papers)R. Bugat (31 shared papers)Gareth J. Veal (7 shared papers)Fabienne Thomas (35 shared papers)Florent Puisset (20 shared papers)Angélo Paci (7 shared papers)Dominique Levêque (3 shared papers)A. Astier (3 shared papers)
- Journals
- Cancer Chemotherapy and Pharmacology (29 papers)Journal of Clinical Oncology (15 papers)European Journal of Cancer (14 papers)Clinical Pharmacokinetics (9 papers)British Journal of Clinical Pharmacology (8 papers)
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
Étienne Chatelut
229 papers receiving 6.5k citations
Peers
Comparison fields: 5 of 125
- Oncology 2.1k
- Genetics 520
- Pharmacology 415
- Hematology 519
- Nephrology 284
Countries citing papers authored by Étienne Chatelut
This map shows the geographic impact of Étienne Chatelut's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Étienne Chatelut with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Étienne Chatelut more than expected).
Fields of papers citing papers by Étienne Chatelut
This network shows the impact of papers produced by Étienne Chatelut. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Étienne Chatelut. The network helps show where Étienne Chatelut may publish in the future.
Co-authors
The 25 scholars most cited alongside Étienne Chatelut, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 235 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 374 | |
| 2 | 2014 | 243 | |
| 3 | 2014 | 212 | |
| 4 | 1995 | 188 | |
| 5 | 2007 | 168 | |
| 6 | 2007 | 158 | |
| 7 | 2007 | 139 | |
| 8 | 2006 | 126 | |
| 9 | 1998 | 123 | |
| 10 | 2008 | 120 | |
| 11 | 2010 | 120 | |
| 12 | 1999 | 118 | |
| 13 | 1993 | 117 | |
| 14 | 2007 | 98 | |
| 15 | Kinetics of the in vivo interconversion of the carboxylate and lactone forms of irinotecan (CPT-11) and of its metabolite SN-38 in patients. | 1994 | 94 |
| 16 | 2006 | 93 | |
| 17 | 2018 | 89 | |
| 18 | 2014 | 76 | |
| 19 | 1998 | 72 | |
| 20 | 2006 | 69 |
About Étienne Chatelut
Étienne Chatelut is a scholar working on Oncology, Molecular Biology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Surgery, having authored 235 papers that have together received 6.6k indexed citations. Recurring topics across this work include Chemotherapy-induced organ toxicity mitigation (34 papers), Cancer therapeutics and mechanisms (34 papers), Cancer Treatment and Pharmacology (30 papers), Colorectal Cancer Treatments and Studies (19 papers), Pharmacogenetics and Drug Metabolism (15 papers), Lung Cancer Research Studies (13 papers), Chronic Lymphocytic Leukemia Research (13 papers) and Acute Lymphoblastic Leukemia research (12 papers). The work is most often cited by research in Oncology (2.1k citations), Genetics (520 citations), Pharmacology (415 citations), Hematology (519 citations) and Nephrology (284 citations). Étienne Chatelut has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Pierre Canal, R. Bugat, Gareth J. Veal, Fabienne Thomas, Florent Puisset, Angélo Paci, Dominique Levêque, A. Astier, Nicolas Widmer and Christophe Bardin. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, Journal of Clinical Oncology, European Journal of Cancer, Clinical Pharmacokinetics and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.